IGFBP1 and cardiovascular disorder: Specifically, IGFBP-1, TFPI, and BMP-4, -7, and -10 have gained significant interest in recent years as potential biomarkers for cardiovascular disease given their demonstrated associations with systemic atherosclerosis, inflammation, thrombosis, endothelial dysfunction, and adverse cardiovascular events [14,15,16,17,18].